Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis.

Literature DB >> 24789955

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis.

Jonas Schupp¹, Mike Becker, Jeannine Günther, Joachim Müller-Quernheim, Gabriela Riemekasten, Antje Prasse.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Chemokines, CC

Year: 2014 PMID： 24789955 DOI： 10.1183/09031936.00131713

Source DB: PubMed Journal: Eur Respir J ISSN： 0903-1936 Impact factor: 16.671

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

Review 1. Functional autoantibodies in systemic sclerosis.

Authors: Jeannine Günther; Judith Rademacher; Jakob M van Laar; Elise Siegert; Gabriela Riemekasten
Journal: Semin Immunopathol Date: 2015-08-21 Impact factor: 9.623

Review 2. Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

Authors: Giuseppina Stifano; Romy Beatriz Christmann
Journal: Curr Rheumatol Rep Date: 2016-01 Impact factor: 4.592

3. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.

Authors: Elizabeth R Volkmann; Donald P Tashkin; Masataka Kuwana; Ning Li; Michael D Roth; Julio Charles; Faye N Hant; Galina S Bogatkevich; Tanjina Akter; Grace Kim; Jonathan Goldin; Dinesh Khanna; Philip J Clements; Daniel E Furst; Robert M Elashoff; Richard M Silver; Shervin Assassi
Journal: Arthritis Rheumatol Date: 2019-11-01 Impact factor: 10.995

Review 4. Myeloid Populations in Systemic Autoimmune Diseases.

Authors: María Morell; Nieves Varela; Concepción Marañón
Journal: Clin Rev Allergy Immunol Date: 2017-10 Impact factor: 8.667

Review 5. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.

Authors: Elizabeth R Volkmann; Donald P Tashkin
Journal: Ann Am Thorac Soc Date: 2016-11

Review 6. Mechanisms of Autoantibody-Induced Pathology.

Authors: Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal: Front Immunol Date: 2017-05-31 Impact factor: 7.561

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis.

Review 1. Functional autoantibodies in systemic sclerosis.

Review 2. Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

3. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.

Review 4. Myeloid Populations in Systemic Autoimmune Diseases.

Review 5. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.

Review 6. Mechanisms of Autoantibody-Induced Pathology.

Review 7. Detection and classification of systemic sclerosis-related interstitial lung disease: a review.

Review 8. Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.

Review 9. [Treatment of systemic sclerosis-associated interstitial lung disease].

Review 10. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.